Literatur
- 1
Abril A, Calamia K T, Cohen M D.
The Churg Strauss syndrome: review and update.
Semin Arthritis Rheum.
2003;
33
106-114
- 2
Aretz H T, Billingham M E, Edwards W D. et al .
Myocarditis. A
histopathologic definition and classification.
Am J Cardiovasc
Pathol.
1987;
1
3-14
- 3
Bardy G H. et al .
Amiodarone or an Implantable Cardioverter-Defibrillator
for Congestive Heart Failure.
N Engl J Med.
2005;
352
225-37
- 4
Baughman K L.
Diagnosis of myocarditis: death of Dallas criteria.
Circulation.
2006;
113
593-595
- 5
Brilakis E S, Olson L J, Berry G J. et al .
Survival outcomes of patients
with giant cell myocarditis bridged by ventricular assist devices.
Asaio J.
2000;
46
569-572
- 6
Cleland J GF, Daubert J C, Erdmann E. et al .
The Effect of Cardiac Resynchronization
on Morbidity and Mortality in Heart Failure.
N Engl J
Med.
2005;
352
1539-1549
- 7
Cooper L T, Baughman K L, Feldman A M. et al .
The role of endomyocardial
biopsy in the management of cardiovascular disease: a scientific
statement from the American Heart Association, the American College
of Cardiology, and the European Society of Cardiology.
Circulation.
2007;
116
2216-2233
- 8
Corssmit E P, Trip M D, Durrer J D.
Loffler’s endomyocarditis in the
ideopathic hypereosinophilic syndrome.
Cardiology.
1999;
91
272-276
- 9
D’Ambrosio A, Patti G, Manzoli A. et al .
The fate of acute myocarditis between spontaneous
improvement and evolution to dilated cardiomyopathy: a review.
Heart.
2001;
85
499-504
- 10
Dickstein K, Cohen-Solal A, Filippatos G. et al .
ESC guidelines for the diagnosis and treatment
of acute and chronic heart failure 2008.
Eur J Heart Fail.
2008;
10
933-989
- 11
Felix S B, Staudt A.
Immunoadsorption for
treatment of dilated cardiomyopathy.
Internist.
2008;
49
51-56
- 12
Frustaci A, Chimenti C, Calabrese F. et al .
Immunosuppressive therapy for active lymphocytic
myocarditis: virologic and immunologic profile of responders versus
non-responders.
Circulation.
2003;
107
857-863
- 13
Gutberlet M, Spors B, Thima T. et
al .
Suspected chronic myocarditis at cardiac MR: diagnostic
accuracy and association with immunohistologically detected inflammation
and viral persistence.
Radiology.
2008;
246
401-409
- 14
Holzmann M, Nicko A, Kuhl U. et
al .
Complication rate of right ventricular endomyocardial
biopsy via the femoral approach: a retrospective and prospective
study analyzing 3048 diagnostic procedures over a 11-year period.
Circulation.
2008;
118
1722-1728
- 15
Kindermann I, Kindermann M, Kandolf R. et al .
Predictors of outcome in patients with
suspected myocarditis.
Circulation.
2008;
118
639-648
- 16
Kuhl U, Lassner D, Pauschinger M. et al .
Prevalence of erythrovirus genotypes in
the myocardium of patients with dilated cardiomyopathy.
J
Med Virol.
2008;
80
1243-1251
- 17
Kuhl U, Noutsias M, Seeberg B. et al .
Immunohistological evidence for a chronic
intramyocardial inflammatory process in dilated cardiomyopathy.
Heart.
1996;
75
295-300
- 18
Kuhl U, Pauschinger M, Bock T. et al .
Parvovirus B19 infection mimicking acute
myocardial infarction.
Circulation.
2003;
108
945-950
- 19
Kuhl U, Pauschinger M, Noutsias M. et al .
High prevalence of viral genomes and multiple
viral infections in the myocardium of adults with „idiopathic” left
ventricular dysfunction.
Circulation.
2005;
111
887-893
- 20
Kuhl U, Pauschinger M, Schwimmbeck P L. et al .
Interferon-beta treatment
eliminates cardiotropic viruses and improves left ventricular function
in patients with myocardial persistence of viral genomes and left
ventricular dysfunction.
Circulation.
2003;
107
2793-2798
- 21
Kuhl U, Schultheiss H P.
Treatment
of chronic myocarditis with corticosteroids.
Eur Heart
J.
1995;
16
168-172
- 22
Kuhl U, Seeberg B, Noutsias M. et al .
Viral persistence in the myocardium is
associated with progressive cardiac dysfunction.
Circulation.
2005;
112
1965-1970
- 23
Lauer B, Niederau C, Kühl U. et al .
Cardiac Troponin T in Patients With Clinically
Suspected Myocarditis.
J Am Coll Cardiol.
1997;
30
1354-1359
- 24 Liu P P, Schultheiss H -P.
Myocarditis. In: Peter Libby et al. Braunwald’s heart disease:
a textbook of cardiovascular medicine. 8th edition. Saunders
Elsevier 2008: 1775ff
- 25
Mangin M, Mahrholdt H, Sechtem U.
Diagnostik der Myokarditis: Darstellung und Bewertung der verfügbaren
Methoden.
Dtsch Med Wochenschr.
2006;
131
1228-1234
- 26
Mahrholdt H, Wagner A, Deluigi C C. et al .
Presentation, Patterns of Myocardial Damage,
and Clinical Course of Viral Myocarditis.
Circulation.
2006;
114
1581-90
- 27
Mahrholdt H, Goedecke C, Wagner A. et al .
Cardiovascular Magnetic resonance Assessment
of Human Myocarditis.
Circulation.
2004;
109
1250-1258
- 28
Maron B J, Towbin J A, Thiene G. et al .
Contemporary definitions and classification
of the cardiomyopathies.
Circulation.
2006;
113
1807-16
- 29
Maron B J, Ackerman M J. et al .
Task
Force 4: HCM and other cardiomyopathies, mitral valve prolapse,
myocarditis, and Marfan syndrome.
J Am Coll Cardiol.
2005;
45
1340-1345
- 30
Martin J, Sarai K, Schindler M. et al .
MEDOS HIA-VAD biventricular assist device
for bridge to recovery in fulminant myocarditis.
Ann Thorac
Surg.
1997;
63
1145-1146
- 31
Mason J W, O’Connell J B, Herskowitz A.
A clinical trial of immunosuppressive therapy
for myocarditis. The Myocarditis Treatment Trial Investigators.
N Engl J Med.
1995;
333
269-275
- 32
Pauschinger M, Bowles N E, Fuentes-Garcia F J. et al .
Detection of adenoviral
genome in the myocardium of adult patients with idiopathic left
ventricular dysfunction.
Circulation.
1999;
99
1348-1354
- 33
Pauschinger M, Noutsias M, Lassner D. et al .
Inflammation, ECG changes and pericardial
effusion: whom to biopsy in suspected myocarditis?.
Clin
Res Cardiol.
2006;
95
569-583
- 34
Schultheiss H P, Piper C, Sowade O. et al .
The effect of subcutaneous treatment with
Interferon-Beta-1b over 24 weeks on safety, virus elimination and
clinical outcome in patients with chronic viral cardiomyopathy.
Circulation.
2008;
118
2312
- 35
Tschope C, Bock C T, Kasner M. et al .
High prevalence of cardiac parvovirus B19
infection in patients with isolated left ventricular diastolic dysfunction.
Circulation.
2005;
111
879-886
- 36
Why H J, Meany B T, Richardson P J.
Clinical and prognostic significance of
detection of enteroviral RNA in the myocardium of patients with
myocarditis or dilated cardiomyopathy.
Circulation.
1994;
89
2582-2589
- 37
Wojnicz R, Nowalany-Kozielska E, Wojciechowska C. et al .
Randomized, Placebo-Controlled
Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy
: Two-Year Follow-Up Results.
Circulation.
2001;
104
39-45
Prof. Dr. med. M. Pauschinger
Medizinische Klinik 8, Kardiologie, Klinikum Nürnberg
Breslauer Straße 201
90471 Nürnberg
Phone: 0911/398-2990
Fax: 0911/398-2988
Email: matthias.pauschinger@klinikum-nuernberg
